One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...
With enpatoran soon entering Phase III clinical trials, the Phase II safety and efficacy results support the drug’s development.
The planned Phase 2 trial will evaluate the efficacy, safety and tolerability of Lucid-MS in people with MS. Quantum ...
Data showed 50% or more of patients reporting >50% improvement in key pain and function scales No adverse events related to dose-limiting ...
Last month, C4 Therapeutics dosed the first patient in its Phase II MOMENTUM trial of cemsidomide, combined with ...
Stocktwits on MSN
VRDN stock plummeted 41% pre-market today — what did its phase 3 active thyroid eye disease trial reveal?
Viridian Therapeutics Inc. (VRDN) shares tanked more than 41% in Monday’s pre-market trade after the company announced results from its Phase 3 REVEAL‑1 Clinical Trial in Active Thyroid Eye Disease.
Hello, and welcome to this market update with the Swedish Diabetes Research Company, Diamyd Medical. On Friday evening, the company announced negative interim results from its Phase III study. We will ...
While orbiting Earth, the moon undergoes a series of phases, each marked by its unique appearance in the sky The moon has captivated humanity since the beginning of time, but what deeper significance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results